Beaumont Hospital — Clinical Trial Site

133 Registered trials

52 Currently recruiting

Organisation

Beaumont Hospital

Location

Dublin 9, Ireland

Identifier

ORG-100041548

Address

Beaumont Road, Beaumont, D09 V2N0, Ireland

Departments

#191: Respiratory medicine
2200: Main Building
372004: Department of Haematology
3903:Oncology
3904:Oncology
8042:Oncology
Anaesthesia and Critical Care
Cancer Clinical Trials & Research Unit
Cancer Clinical Trials and Research Unit
Cancer Clinical Trials Research Unit
Cancer Clinical Trials Unit
Cancer Clinical Trials Unit & Research Unit
Clinical Oncology
Clinical Research Centre
Clinical Trials & Research Unit
D10-514 : Nephrology
Department of Haematology
Department of Medicine
Department of Medicine, RCSI
Department of Medicine/ RCSI
Dept. of Anaesthesia and Intensive Care Medicine
Emergency Medicine
Endocrinology
Gastroenterology
Gastroenterology and Hepatology
Gastroenterology Department
Haematology
Haematology department
Hepatology Unit
ICU
Infectious Diseases
Intensive Care Unit
Medical Oncology
N/A
NA
Neurology
Neurology Department
Not Applicable
Oncology
Oncology Department
Oncology Clinical Trials Unit
Oncology department
Onkology
Respiratory
Respiratory Medicine
Rheumatology
Rheumatology Department
Royal College of Surgeons in Ireland (RCSI)
Stroke

Clinical trials at this site (133)

Search interface

Vaccination to prevent Mpox Infection (MPOX-VAX Study) Ended

2023-507881-19-00 Mpox infection 6 2024-06-29
A study to evaluate the efficacy, safety, and tolerability of using an oral once-daily 2 drug regimen compared to an oral once-daily 3 drug … Ended

2023-504993-40-00 Human immunodeficiency virus (HIV) 5 2024-02-14
A Trial of Lu AG13909 in Participants with Congenital Adrenal Hyperplasia Ended

2023-503711-15-00 Congenital adrenal hyperplasia 7 2024-01-25
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer (DeLLphi-304) Ended

2022-502669-14-00 Small cell lung cancer (SCLC) 5 2023-12-18
Phase 3 study of belzutifan plus pembrolizumab as adjuvant treatment in renal cell carcinoma (RCC) Ended

2023-505023-31-00 Renal cell carcinoma 5 2023-11-17
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
A study to test trimodulin in adult hospitalized patients with severe pneumonia Ended

2022-501352-28-00 Severe community-acquired pneumonia (sCAP) 5 2023-06-07
ETOP 22-22 ADEPPT: A study of adagrasib for patients with KRASG12C-mutant non-small cell lung cancer (NSCLC), who are elderly or who are unw… Ended

2023-510463-35-00 Patients with KRASG12C-mutant NSCLC, including patients 4 2023-04-26
A study into the efficacy and safety of dazucorilant (CORT113176) in patients with Amyotrophic Lateral Sclerosis Ended

2024-514082-19-00 Amyotrophic Lateral Sclerosis 4 2022-11-04
Study of ceralasertib plus durvalumab versus docetaxel for patients with advanced or metastatic non-small cell lung cancer Ended

2023-509429-37-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5 2022-10-03
A clinical study that compares a treatment with Iberdomide, Daratumumab and Dexamethasone against a treatment with Daratumumab, Bortezomib, … Ended

2024-510800-35-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-06-17
Clinical Trial of MK-7684A with chemotherapy for extensive stage small cell lung cancer (ES-SCLC) Ended

2023-503517-30-00 Extensive-stage small-cell lung cancer 5 2022-04-01
Isa-RVD Study: Phase II, Multi-centre, Single-Arm, Open-Label Study to evaluate the efficacy and safety of the combination regimen Isatuxima… Ended

2024-512749-18-00 Newly diagnosed Multiple Myeloma 4 2022-03-03
A clinical study to assess the efficacy of alpelisib plus fulvestrant in participants with HR-positive, HER2-negative, advanced breast cance… Ended

2023-509133-39-00 Hormone receptor positive, HER2-negative advanced breas 5 2021-11-29
A Phase 3 Open Label, Randomized Study of LOXO 305 versus Investigator's Choice of Idelalisib plus Rituximab or Bendamustine plus Rituximab … Ended

2023-507697-40-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-07-05
A Study of Relatlimab plus Nivolumab in Combination with Chemotherapy vs. Nivolumab in Combination with Chemotherapy in Participants with St… Ended

2023-508372-10-00 Non small Cell Lung cancer 4 2021-05-19
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended

2022-502122-41-00 Clear cell renal cancer 5 2021-05-11
Research study on whether semaglutide works in people with non-alcoholic steatohepatitis (NASH) Ended

2023-506962-30-00 Non-alcoholic steatohepatitis (NASH) 5 2021-03-29
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation Ended

2023-507263-19-00 Advanced Non-Small Cell Lung Cancer 5 2020-12-23
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Ended

2022-501522-38-00 Chronic lymphocytic leukemia; Non-Hodgkin's lymphoma; M 5 2020-09-04
A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant trea… Ended

2023-510357-42-00 hormone receptor (HR)-positive, HER2-negative, early br 5 2019-05-22
Long Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis. Ended

2023-505699-31-00 Ulcerative Colitis 5 2017-01-02